We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,046 results
  1. Addressing comprehensive complexities a striking familial hypercholesterolemia case study

    Background

    Premature aortic involvement and comprehensive management strategies in familial hypercholesterolemia familial hypercholesterolemia (FH), a...

    Shazia Rasheed, Ghulam Kubra, ... Syed Ghazi Abbas Rizvi in The Egyptian Heart Journal
    Article Open access 20 April 2024
  2. Measuring Costs of Cardiovascular Disease Prevention for Patients with Familial Hypercholesterolemia in Administrative Claims Data

    Introduction

    Familial hypercholesterolemia is a common genetic condition that significantly increases an individual’s risk of cardiovascular events...

    Lauren E. Passero, Megan C. Roberts in High Blood Pressure & Cardiovascular Prevention
    Article 03 February 2024
  3. The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

    Purpose of Review

    The current review discusses the importance and significance of differentiating monogenic familial hypercholesterolemia (FH) from...

    Fistra Janrio Tandirerung in Current Cardiology Reports
    Article Open access 09 September 2022
  4. Familial hypercholesterolemia care by Dutch pediatricians—mind the gaps

    Purpose

    Familial hypercholesterolemia (FH) leads to elevated low-density lipoprotein cholesterol levels, which increases the risk of premature...

    Sibbeliene E. van den Bosch, Barbara A. Hutten, ... Willemijn E. Corpeleijn in European Journal of Pediatrics
    Article Open access 18 June 2024
  5. Early echocardiographic signs of cardiovascular affection in pediatric familial hypercholesterolemia

    Familial hypercholesterolemia (FH) is a rare autosomal dominant genetic disorder caused by defective low-density lipoprotein (LDL) receptors or...

    Hossam Ibrahim, Hend Saad, ... Gaser Abdelmohsen in European Journal of Pediatrics
    Article Open access 21 July 2023
  6. A mini-review of efficacy, safety, and influence of novel evinacumab on familial hypercholesterolemia

    Background

    Familial hypercholesterolemia (FH) poses a substantial risk of cardiovascular diseases. The recent approval of evinacumab signifies a...

    Gbolahan Olatunji, Emmanuel Kokori, ... Nicholas Aderinto in The Egyptian Journal of Internal Medicine
    Article Open access 26 June 2024
  7. Sex Differences in Familial Hypercholesterolemia

    Purpose of Review

    This review aims to summarize the existing research on sex differences in familial hypercholesterolemia (FH) across the lifespan.

    ...
    Marianne Klevmoen, Janneke W.C.M. Mulder, ... Kirsten B. Holven in Current Atherosclerosis Reports
    Article Open access 10 October 2023
  8. Does Genotype Affect the Efficacy of PCSK9 Inhibitors in the Treatment of Familial Hypercholesterolemia?

    Purpose of Review

    This review discusses whether patients’ genotype affects the efficacy of PCSK9 inhibitors in treating familial hypercholesterolemia...

    Fistra Janrio Tandirerung in Cardiovascular Drugs and Therapy
    Article Open access 23 August 2023
  9. Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing

    Purpose of Review

    Heterozygous familial hypercholesterolemia (HeFH) is the most common monogenic autosomal dominant disorder. However, the condition...

    Pablo Corral, Carlos A. Aguilar Salinas, ... Laura Schreier in Current Atherosclerosis Reports
    Article 03 November 2023
  10. Peripheral artery disease: an underdiagnosed condition in familial hypercholesterolemia? A systematic review

    Purpose

    Familial hypercholesterolemia (FH) is one of the most common inherited diseases characterized by elevated LDL-cholesterol levels, leading to...

    Elisa Acitelli, Alexis F. Guedon, ... Marianna Maranghi in Endocrine
    Article Open access 08 March 2024
  11. Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?

    Purpose of Review

    Familial hypercholesterolemia is a high cardiovascular risk disorder. We will review the role of lipoprotein(a) in cardiovascular...

    Rodrigo Alonso, Rosa Argüeso, ... Pedro Mata in Current Atherosclerosis Reports
    Article 07 April 2022
  12. The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis

    Purpose of Review

    Familial Hypercholesterolemia (FH) is a common genetic disorder characterized by lifelong elevation of severely elevated plasma...

    Ryan Lokkesmoe, Luke Hamilton in Current Atherosclerosis Reports
    Article 18 June 2024
  13. Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges

    Background

    It is now well established that atherosclerosis begins in childhood and evolves through adolescence and young adulthood, ultimately...

    Giuseppe Banderali, Maria Elena Capra, ... Cristina Pederiva in Italian Journal of Pediatrics
    Article Open access 15 July 2022
  14. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)

    Purpose of Review

    Familial hypercholesterolemia (FH) and hyperlipoproteinemia(a) are relatively common disorders, posing a significant health burden...

    Maya S. Safarova, Patrick M. Moriarty in Current Atherosclerosis Reports
    Article 05 June 2023
  15. Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia

    Purpose of Review

    Individuals with familial hypercholesterolemia have very high risk of cardiovascular disease due to lifelong elevations in LDL...

    Anne Langsted, Børge G. Nordestgaard in Current Atherosclerosis Reports
    Article 02 February 2022
  16. Parental Attitudes and Ideas Regarding Newborn Screening for Familial Hypercholesterolemia

    Background

    Familial hypercholesterolemia (FH) is an inherited disease which causes premature atherosclerotic cardiovascular disease. However, less...

    Katie Tobik, Kate Murphy Orland, ... Amy L. Peterson in Maternal and Child Health Journal
    Article 25 March 2023
  17. An update on lipid apheresis for familial hypercholesterolemia

    Familial hypercholesterolemia (FH) is an inherited metabolic defect leading to increased total cholesterol and low-density cholesterol (LDL) from...

    Christina Taylan, Lutz T. Weber in Pediatric Nephrology
    Article Open access 25 April 2022
  18. Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand

    Background

    Familial hypercholesterolemia (FH) is an under-diagnosed autosomal co-dominant genetic disorder characterized by very high plasma levels of...

    Prakash Kumar, Shashi Ranjan Prasad, ... Sajalendu Ghosh in The Egyptian Heart Journal
    Article Open access 17 December 2022
  19. Different clinical phenotypes of a pair of siblings with familial hypercholesterolemia: a case report and literature review

    Background

    Familial hypercholesterolemia (FH) leads to high plasma low-density lipoprotein cholesterol (LDL-C) levels and early cardiovascular...

    Ze-** Wang, Ya-Jie Wu, ... Ke-Ji Chen in BMC Cardiovascular Disorders
    Article Open access 01 May 2023
  20. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice

    Purpose of Review

    Genetic testing has proven utility in identifying and diagnosing individuals with FH. Here we outline the current landscape of...

    Eric P. Tricou, Kelly M. Morgan, ... Amy C. Sturm in Current Atherosclerosis Reports
    Article 15 April 2023
Did you find what you were looking for? Share feedback.